Our data indicated that NLRP3 inflammasome in MDSCs was activated by arachidonic acid through FATP2 during fatty graft injury, and it further induced the IL-17 production of CD4+ T cells, promoting the tumour recurrence post liver transplantation. Here, NLRP3 is linked to neoplasm.